β-Lactoglobulin-based amorphous solid dispersions: A graphical review on the state-of-the-art

Xuezhi Zhuo1, Ieva Jasiukenaite1, Korbinian Löbmann1

  • 1Zerion Pharma A/S, Fruebjergvej 3, 2100 Copenhagen, Denmark.

Summary

Whey protein isolate, specifically beta-lactoglobulin (BLG), shows promise for creating amorphous solid dispersions (ASDs) that enhance drug solubility and oral bioavailability. BLG-based ASDs offer effective amorphous stabilization and improved drug dissolution compared to traditional polymers.